Prenetics Global (PRE)
(Delayed Data from NSDQ)
$4.61 USD
-0.36 (-7.24%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.62 +0.01 (0.22%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PRE 4.61 -0.36(-7.24%)
Will PRE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PRE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRE
Prenetics Global Limited (PRE) Is Considered a Good Investment by Brokers: Is That True?
Wall Street Analysts See Prenetics Global Limited (PRE) as a Buy: Should You Invest?
PRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Prenetics Global Limited (PRE) Stock Moves -1.14%: What You Should Know
Should You Invest in Prenetics Global Limited (PRE) Based on Bullish Wall Street Views?
Prenetics Global Limited (PRE) Gains As Market Dips: What You Should Know
Other News for PRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
First Horizon Declares Cash Dividends on Common and Preferred Stock
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers